- Genprex Inc Global One Media Interview TranscriptJun 22, 2023
- Genprex Inc at Sidoti & Company May Micro-Cap Virtual Conference TranscriptMay 11, 2023
- Genprex Inc KOL Event: Novel Gene Therapy to Treat Type 1 Diabetes TranscriptApr 12, 2023
- Genprex Inc at LD Micro Main Event TranscriptOct 26, 2022
- Genprex Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Genprex Inc at LD Micro Invitational Conference (Virtual) TranscriptJun 08, 2022
- Genprex Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Genprex Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- Genprex Inc C-Suite Interview with Noble Capital Markets TranscriptApr 22, 2021
- Cell and Gene Meeting on Mesa - Genprex TranscriptJan 08, 2021
- Genprex launches new branding for its lead drug REQORSA in preparation for upcoming studies TranscriptNov 06, 2020
- Genprex (GNPX) Virtual Road Show with CEO Rodney Varner TranscriptSep 15, 2020
- Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir TranscriptAug 04, 2020
Genprex Inc C-Suite Interview with Noble Capital Markets Transcript
(Introduction playing)
Welcome to the C-Suite Series presented by ChannelCheck and NOBLE Capital Markets. NOBLE is an SEC-registered, FINRA-licensed broker dealer and the source of the equity research available on ChannelCheck. Today's interview features Genprex; Nasdaq ticker symbol, GNPX.
NOBLE senior research analyst Robert LeBoyer interviews Genprex's President and CEO, Rodney Varner. Visit channelcheck.com, or click the link in the description for NOBLE's research on Genprex, as well as news and events market data.
And now, here's Robert and Rodney.
Hello. I'm Robert LeBoyer, senior analyst at NOBLE Capital. With me today is Rodney Varner, the CEO of Genprex. A company developing a gene therapy platform for cancer and diabetes.
Welcome, Mr. Varner. Can I ask you to describe a little bit of what you're doing and the markets that you're serving?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)